dn 1417 has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engel, WK; Hawkins, EF | 1 |
| Goodman, RR; Hanson, PA; Hawley, RJ; Kratz, R; McCutchen, CB; Sirdofsky, M | 1 |
2 other study(ies) available for dn 1417 and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: possible clinical implications.
Topics: Amyotrophic Lateral Sclerosis; Animals; Binding, Competitive; Central Nervous System; Male; Peptides, Cyclic; Piperazines; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 1985 |
Treatment of amyotrophic lateral sclerosis with the TRH analog DN-1417.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Drug Evaluation; Hormones; Humans; Male; Middle Aged; Muscles; Thyrotropin-Releasing Hormone | 1987 |